Pfizer is exploring strategic alternatives for its Animal Health and Nutrition businesses following a business portfolio review. The company is considering options for a full or partial separation of these businesses through a spin-off, sale, or other transaction. “Both Animal Health and Nutrition are strong businesses with attractive customer bases and solid fundamentals, but distinct enough from our core businesses that their value may be best maximized outside the company,” said Ian Read, pr...